NASDAQ:IMI - Intermolecular Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$1.70 -0.06 (-3.41 %)
(As of 07/16/2018 04:00 PM ET)
Previous Close$1.76
Today's Range$1.65 - $1.80
52-Week Range$0.86 - $1.98
Volume94,800 shs
Average Volume61,851 shs
Market Capitalization$87.30 million
P/E RatioN/A
Dividend YieldN/A
Beta1.1
Intermolecular logoIntermolecular, Inc. engages in the development of advanced materials using high productivity combinatorial (HPC) technology platform for the semiconductors, consumer electronics, automotive, and aerospace industries worldwide. The company's HPC platform includes Tempus processing tools, automated characterization methods, and informatics analysis software for research and development using combinatorial process systems in concert with established chemical vapor deposition, physical vapor deposition, and atomic layer deposition methods. It serves various markets, including semiconductor, glass, advanced alloys, light-emitting diodes, flat-panel displays, and others. The company was formerly known as The BEP Group, Inc. and changed its name to Intermolecular, Inc. in November 2004. Intermolecular, Inc. was founded in 2004 and is headquartered in San Jose, California.

Receive IMI News and Ratings via Email

Sign-up to receive the latest news and ratings for IMI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Semiconductors & related devices
Sub-IndustrySemiconductors
SectorComputer and Technology
SymbolNASDAQ:IMI
CUSIP45882D10
Phone408-582-5700

Debt

Debt-to-Equity RatioN/A
Current Ratio7.84
Quick Ratio7.85

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$37.20 million
Price / Sales2.27
Cash FlowN/A
Price / CashN/A
Book Value$0.73 per share
Price / Book2.33

Profitability

EPS (Most Recent Fiscal Year)N/A
Net Income$-10,400,000.00
Net Margins-14.05%
Return on Equity-14.29%
Return on Assets-11.57%

Miscellaneous

Employees105
Outstanding Shares49,600,000
Market Cap$87.30

The Truth About Cryptocurrencies

Intermolecular (NASDAQ:IMI) Frequently Asked Questions

What is Intermolecular's stock symbol?

Intermolecular trades on the NASDAQ under the ticker symbol "IMI."

How were Intermolecular's earnings last quarter?

Intermolecular Inc (NASDAQ:IMI) posted its quarterly earnings data on Tuesday, May, 8th. The semiconductor company reported ($0.01) EPS for the quarter, beating analysts' consensus estimates of ($0.02) by $0.01. The semiconductor company had revenue of $9.68 million for the quarter. Intermolecular had a negative net margin of 14.05% and a negative return on equity of 14.29%. View Intermolecular's Earnings History.

What price target have analysts set for IMI?

1 brokers have issued 1 year price targets for Intermolecular's stock. Their forecasts range from $3.00 to $3.00. On average, they anticipate Intermolecular's share price to reach $3.00 in the next year. This suggests a possible upside of 76.5% from the stock's current price. View Analyst Ratings for Intermolecular.

What is the consensus analysts' recommendation for Intermolecular?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Intermolecular in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."

Who are some of Intermolecular's key competitors?

Who are Intermolecular's key executives?

Intermolecular's management team includes the folowing people:
  • Mr. Christian F. Kramer, Pres, CEO & Director (Age 56)
  • Mr. Bill Roeschlein, Sr. VP, CFO & Principal Accounting Officer (Age 48)
  • Mr. C. Richard Neely Jr., Consultant (Age 64)
  • Mr. Milind Weling, Sr. VP of Programs & Operations
  • Dr. Karl Littau, Chief Technology Officer

Has Intermolecular been receiving favorable news coverage?

Media coverage about IMI stock has been trending somewhat positive this week, Accern Sentiment Analysis reports. Accern scores the sentiment of news coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Intermolecular earned a news impact score of 0.16 on Accern's scale. They also gave news articles about the semiconductor company an impact score of 45.95 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company's share price in the next several days.

How do I buy shares of Intermolecular?

Shares of IMI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Intermolecular's stock price today?

One share of IMI stock can currently be purchased for approximately $1.70.

How big of a company is Intermolecular?

Intermolecular has a market capitalization of $87.30 million and generates $37.20 million in revenue each year. Intermolecular employs 105 workers across the globe.

How can I contact Intermolecular?

Intermolecular's mailing address is 3011 NORTH FIRST STREET, SAN JOSE CA, 95134. The semiconductor company can be reached via phone at 408-582-5700 or via email at [email protected]


MarketBeat Community Rating for Intermolecular (NASDAQ IMI)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  104 (Vote Outperform)
Underperform Votes:  146 (Vote Underperform)
Total Votes:  250
MarketBeat's community ratings are surveys of what our community members think about Intermolecular and other stocks. Vote "Outperform" if you believe IMI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IMI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/16/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.